Freenome, Inc. SEC filings FRNM

Freenome, Inc. has 135 filings in SEC EDGAR's recent list, going back to Apr 16, 2024. Its latest annual report, Form 10-K, was filed on Mar 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 15, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Freenome, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Oct 20, 2026 Oct 20, 2026
8-K/A Amended current report
Acquisition or sale of assets
Aug 13, 2026 Jul 20, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 27, 2026 Jul 27, 2026
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Jul 24, 2026 Jul 20, 2026
8-K Current report
Shareholder vote results
Jul 15, 2026 Jul 15, 2026
8-K Current report
Other events
Jul 9, 2026 Jul 9, 2026
8-K Current report
Regulation FD disclosure
Jun 18, 2026 Jun 18, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 10, 2026 Jun 10, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Dec 5, 2025 Dec 5, 2025
8-K/A Amended current report
Other events
Aug 8, 2024 Jun 13, 2024
8-K Current report
Other events
Jun 20, 2024 Jun 13, 2024
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Jun 13, 2024 Jun 11, 2024

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
FRNM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Brisbane, CA
SEC filer status
, Emerging growth company
SEC CIK
2017526
Former names
Perceptive Capital Solutions Corp (until Jul 15, 2026)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.